Charles River Laboratories International (CRL) Receivables - Net (2016 - 2025)
Charles River Laboratories International (CRL) has 17 years of Receivables - Net data on record, last reported at $708.9 million in Q4 2025.
- For Q4 2025, Receivables - Net fell 1.67% year-over-year to $708.9 million; the TTM value through Dec 2025 reached $708.9 million, down 1.67%, while the annual FY2025 figure was $708.9 million, 1.67% down from the prior year.
- Receivables - Net reached $708.9 million in Q4 2025 per CRL's latest filing, down from $748.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $812.4 million in Q1 2024 and bottomed at $610.6 million in Q1 2021.
- Average Receivables - Net over 5 years is $741.2 million, with a median of $761.6 million recorded in 2022.
- Peak YoY movement for Receivables - Net: increased 22.35% in 2021, then decreased 7.62% in 2024.
- A 5-year view of Receivables - Net shows it stood at $642.9 million in 2021, then rose by 17.03% to $752.4 million in 2022, then grew by 3.72% to $780.4 million in 2023, then fell by 7.62% to $720.9 million in 2024, then decreased by 1.67% to $708.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $708.9 million in Q4 2025, $748.3 million in Q3 2025, and $767.6 million in Q2 2025.